HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db06-1283v1 56/4/1177    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, H.-Y. Articles by Shin, S.-J. Search for Related Content PubMed PubMed Citation Articles by Lin, H.-Y. Articles by Shin, S.-J. Social Bookmarking                What's this?

SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes

¹ Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
² Division of Endocrinology and Metabolism, E-Da Hospital, Kaohsiung, Taiwan
³ Division of Endocrinology and Metabolism, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

Address correspondence and reprint requests to Shyi-Jang Shin, MD, PhD, Division of Endocrinology and Metabolism, Kaohsiung Medical University Hospital, 100 Shih-Chuan 1st Rd., Kaohsiung 80708, Taiwan. E-mail: sjshin{at}kmu.edu.tw

Abbreviations: ACR, albumin-to-creatinine ratio; NF-B, nuclear factor-B

OBJECTIVE—SUMO4 mRNA was recently found to be mainly expressed in the kidney, and the methionine-to-valine substitution at codon 55 (M55V) variant of SUMO4 may induce higher nuclear factor-B (NF-B) activity. Because NF-B is known to mediate the development of diabetic nephropathy, we examined the association between the SUMO4 M55V variant and the severity of diabetic nephropathy.

RESEARCH DESIGN AND METHODS—We recruited a total of 430 patients with type 2 diabetes. The M55V (rs237025, 163AG) polymorphism of SUMO4 was genotyped by real-time PCR, and urine albumin concentration was measured by radioimmunoassay.

RESULTS—The frequencies of SUMO4 AA, GA, and GG were 52.6, 40.7, and 6.7%, respectively, in the normoalbuminuric group; 45.5, 47.3, and 7.1% in the microalbuminuric group; and 36.9, 46.2, and 16.9% in the macroalbuminuric group. We detected a significant linear trend for SUMO4 genotype between the macroalbuminuric and normoalbuminuric groups. The mean urine albumin–to–creatinine ratio (42.3 ± 108.82 mg/mmol) in the GG group was significantly higher than in the AA (14.9 ± 51.49 mg/mmol) and GA (17.0 ± 43.74 mg/mmol) groups. Multivariate logistic regression analysis showed the SUMO4 M55V variant to be independently associated with the severity of diabetic nephropathy.

CONCLUSIONS—This study indicates that the SUMO4 gene M55V variant is associated with severity of diabetic nephropathy in patients with type 2 diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Rudofsky Jr., A. Schlotterer, P. P. Nawroth, A. Bierhaus, and A. Hamann Comment on: Lin et al. (2007) SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes: Diabetes 56:1177 1180 Diabetes, August 1, 2007; 56(8): e11 - e11. [Full Text] [PDF]

				S.-J. Shin, H.-Y. Lin, C.-L. Wang, P.-J. Hsiao, and K.-D. Lin Response to Comment on: Lin et al. (2007) SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes: Diabetes 56:1177 1180 Diabetes, August 1, 2007; 56(8): e12 - e13. [Full Text] [PDF]